Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Singtel Innov8 is the corporate venture capital arm of Singtel, investing in early-revenue to growth-stage technology startups focused on areas like 5G, cybersecurity, AI, and digital services with an evergreen fund of approximately US$350 million. It has invested in over 90 startups and achieved more than 35 exits.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Singtel Innov8.